October 09, 2025

Medical Oddities: What Your Sleep Says About You

Five stories span sleep neuroscience, anti-aging dog training, a citrus misdiagnosis, green tea’s post-op benefits, and a gummy binge gone wrong.

Conexiant

October 06, 2025

Dupilumab Shows High Treatment Persistence in AD

Biologics target type 2 inflammation in atopic dermatitis, improving skin barrier and symptoms.

Conexiant

October 01, 2025

Remibrutinib Gains FDA Nod for Urticaria

First oral BTK inhibitor approved for antihistamine-resistant chronic spontaneous urticaria, targeting mast cell–driven immune dysregulation

Conexiant

September 30, 2025

Multiple Suits: Red Flag or Noise?

Cosmetic surgery chains expanded with emergency-licensed, out-of-state surgeons; lawsuits and disciplinary records challenge credentialing, “fellowship” claims, and patient protections in an industry without public complication tracking.

KFF Health News

September 29, 2025

FDA Expands Options for Pediatric Psoriasis, PsA

The FDA has approved the first IL-23 inhibitor for pediatric patients with plaque psoriasis and psoriatic arthritis.

Conexiant

September 19, 2025

New Topical JAK Inhibitor Option for Kids

The FDA approved ruxolitinib cream for children aged 2 to 11 with mild to moderate atopic dermatitis.

Conexiant

September 17, 2025

Global Survey Finds Suicidal Ideation Risk With Atopic Eczema

Obesity, severe disease, and insomnia raise suicidal ideation risk in atopic eczema

Conexiant

June 12, 2024

FAc Implant Shows Sustained Improvement in Uveitis

Long-term study highlights effectiveness of fluocinolone acetonide implant in managing non-infectious posterior uveitis, maintaining stable intraocular pressure.

Conexiant

November 27, 2024

Processed Foods Linked to Active Psoriasis: Study

French researchers in JAMA Dermatology linked high ultraprocessed food consumption to increased rates of psoriasis, emphasizing the need for further investigation.

Conexiant